Trials / Completed
CompletedNCT01096979
An Evaluation of the Safety and Efficacy of LIPO-102 for the Reduction of Subcutaneous Abdominal Adiposity
A Double-Masked, Evaluation of the Safety and Efficacy of LIPO-102 for the Reduction of Subcutaneous Abdominal Adiposity
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Neothetics, Inc · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This is a double-masked evaluation of the safety and efficacy of LIPO-102 for the reduction of subcutaneous abdominal adiposity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | LIPO-102 | subcutaneous injection |
| DRUG | Placebo | Placebo |
Timeline
- Start date
- 2009-10-01
- Primary completion
- 2010-03-01
- Completion
- 2010-03-01
- First posted
- 2010-03-31
- Last updated
- 2015-03-26
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01096979. Inclusion in this directory is not an endorsement.